July 12, 2022 Comments Off on New patent for Veloxis Pharms drug ENVARSUS XR Posted in: Patent Added Annual Drug Patent Expirations for ENVARSUS+XR Envarsus Xr is a drug marketed by Veloxis Pharms Inc and is included in one NDA. It is available from one supplier. There are…
The post New patent for Veloxis Pharms drug ENVARSUS XR appeared first on Drug…
July 12, 2022 Comments Off on New patent for Novartis drug MAYZENT Posted in: Patent Added Annual Drug Patent Expirations for MAYZENT Mayzent is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are two patents protecting…
The post New patent for Novartis drug MAYZENT appeared first on DrugPaten…
